newsfilter
← Latest News
Business Wire·

OmniAb Announces Completion of Spin-Off and Business Combination

Leading Antibody Discovery Technologies Enable Development of Innovative Therapeutics Regular-way Trading of OABI Begins November 2, 2022 on Nasdaq OmniAb, Inc. (NASDAQ:OABI) today announced the completion of the